GC180 Benign Prostatic Hyperplasia, Bladder Outlet Obstruction And Urinary Retention
Benign prostatic hyperplasia is a non-malignant enlargement of the prostate gland that can cause bladder outlet obstruction and, if untreated, may progress to acute or chronic urinary retention.
Benign Prostatic Hyperplasia, Bladder Outlet Obstruction & Urinary Retention
This GC 180 lecture is a high-yield urology lecture that covers three deeply interconnected topics that form one of the most common surgical presentation pathways you'll encounter: a man who cannot pass water. The lecture is structured as:
- Physiology of micturition – how normal voiding works (storage vs. emptying)
- Pathophysiology of urinary retention – what goes wrong and why
- Clinical management of urinary retention – the practical approach from A&E to definitive care
The unifying concept: the lower urinary tract has two jobs — store urine and expel urine. When either function fails (usually due to obstruction or impaired detrusor contractility), the patient retains urine. BPH is the most common cause of bladder outlet obstruction (BOO) in men, and BOO is the most common cause of acute urinary retention (AROU). This lecture connects to GC 209 (urinary incontinence/OAB), GC 183 (urological malignancies including CA prostate), and the paediatric urology lecture (GC 213).
Learning objectives from the lecture [1]:
- Learn the pathophysiology of micturition – structure and function, storage vs emptying phase
- Understand how urinary retention develops
- Grasp the concept of BOO
- Discuss the clinical management of urinary retention
The lower urinary tract differs between sexes [1]:
- Male: Urinary Bladder + Prostate + Urethra
- Female: Urinary Bladder + Urethra
This anatomical difference is crucial — the prostate sits between the bladder neck and the external sphincter in males, wrapping around the prostatic urethra. This is precisely why BPH causes obstruction in men but not women. In women, the shorter urethra and absence of prostate mean BOO is much less common, and retention is more often due to detrusor underactivity.
Prostate Anatomy (Supplementary, exam-relevant)
| Zone | Location | Clinical Significance |
|---|---|---|
| Transitional zone | Surrounds prostatic urethra | BPH arises here — grows inward → compresses urethra early → symptomatic |
| Peripheral zone | Posterior, largest zone | Prostate cancer arises here — grows outward → presents late |
| Central zone | Surrounds ejaculatory ducts | Less clinically relevant |
| Anterior fibromuscular stroma | Anterior | Non-glandular |
This is why BPH does NOT predispose to prostate cancer — they arise in completely different zones [3].
2. Physiology of Micturition
Normal voiding has two phases [1]:
| Phase | Requirements |
|---|---|
| STORAGE | Accommodation of urine at low pressure with appropriate sensation |
| Bladder outlet remains closed at rest and during increased intra-abdominal pressure | |
| No involuntary bladder contraction | |
| EMPTYING | Coordinated contraction of bladder smooth muscle of adequate magnitude and duration |
| Lowering of resistance at the level of smooth and striated sphincter | |
| Absence of anatomic obstruction |
Why this matters: Each requirement for normal voiding can fail. When storage fails → incontinence. When emptying fails → retention. This is the framework for understanding ALL lower urinary tract pathology.
2.2 Innervation of the Lower Urinary Tract
Three nerve systems control the LUT [1]:
| System | Origin | Target | Receptor | Effect |
|---|---|---|---|---|
| Sympathetic | T10-L2 (hypogastric nerve) | Detrusor | β3-adrenergic | Relaxation (storage) |
| Bladder neck / Prostate | α1-adrenergic | Contraction (continence) | ||
| Parasympathetic | S2-S4 (pelvic nerve) | Detrusor | M3 muscarinic | Contraction (voiding) |
| Somatic | Onuf's nucleus → S2-4 (pudendal nerve) | External sphincter (rhabdosphincter) | Nicotinic | Contraction (continence) |
High-Yield Receptor Table
This receptor table is the pharmacological basis for ALL BPH/LUTS medications:
- α1 blockers (tamsulosin) → relax bladder neck/prostate → relieve dynamic obstruction
- β3 agonists (mirabegron) → relax detrusor → improve storage (used in OAB)
- Antimuscarinics (oxybutynin) → block M3 → reduce involuntary detrusor contractions (OAB), but can CAUSE retention
- 5α-reductase inhibitors (finasteride) → reduce DHT → shrink prostate → relieve static obstruction
Afferent fibres [1]:
- Present in hypogastric, pelvic (majority), and pudendal nerves
- Myelinated Aδ fibres (sense normal bladder distension)
- Unmyelinated C-fibres (sense irritation/pain; normally silent, become active in pathology)
- All relay to higher centres
Two key centres [1]:
- Pontine Micturition Centre (PMC / Barrington's nucleus) – the "on-off switch" for voiding
- Suprapontine control (Cerebral cortex) – voluntary inhibition/initiation
During storage [1]:
- Myelinated Aδ sensory fibres send low-level afferent signals (vesicosympathetic 'storage' reflex)
- Sympathetic pathway: ACTIVE (+ve)
- Parasympathetic pathway: INHIBITED (-ve)
- Somatic pathway: ACTIVE (+ve)
- Results in:
- Detrusor relaxation (β3-adrenergic)
- Internal urethral sphincter contraction (α1-adrenergic)
- External urethral sphincter contraction (nicotinic)
Why this works: Low-level bladder filling activates sympathetic tone via a spinal reflex. The bladder relaxes to accommodate urine (receptive relaxation following Laplace's Law: T = P×R / 2d), while both sphincters contract to maintain continence. The parasympathetic drive to the detrusor is actively suppressed.
During voiding [1]:
- Higher level of afferent firing signals to PMC + "OK" signal from cerebral cortex
- The on-off switch is 'flipped' — PMC sends signals to:
- Sympathetic: INHIBITED (-ve)
- Parasympathetic: ACTIVE (+ve)
- Somatic: INHIBITED (-ve)
- Results in:
- Detrusor contraction (M3 muscarinic)
- Internal urethral sphincter relaxation
- External urethral sphincter relaxation
Voiding reflex pathway [1]: Critical level of afferent activity from tension receptors in bladder → PMC (+ cortical input) → three simultaneous outputs:
- Activation of sacral parasympathetic efferent to bladder → Contraction of detrusor
- Activation of sacral parasympathetic to urethra → Relaxation of urethral smooth muscle
- Inhibition of somatic pathway to sphincter → Relaxation of striated sphincter → Voiding
In spinal cord injury (SCI), the descending control from PMC is interrupted [1]:
- The detrusor contracts BUT the sphincter contracts simultaneously (should relax)
- This is called Detrusor Sphincter Dyssynergia
- Results in extremely high intravesical pressures → upper tract damage
Why DSD occurs: The PMC normally coordinates detrusor contraction WITH sphincter relaxation as a single package. When the spinal cord is damaged above the sacral segments (suprasacral lesion), local sacral reflexes can still trigger detrusor contractions, but the inhibitory signal to the sphincter (which comes from the PMC) cannot get through. Both muscles fire at once.
SCI and Bladder
Don't confuse the phases:
- Spinal shock phase (acute SCI) → areflexic bladder → AROU/overflow incontinence (everything shuts down)
- After spinal shock resolves → hyperreflexic bladder with DSD → urge incontinence ± high-pressure retention → risk of reflux nephropathy
- Sacral cord/cauda equina lesion → areflexic bladder (permanent) → overflow incontinence
3. Pathophysiology of Urinary Retention
Two types of retention [1]:
| Feature | Acute Retention (AROU) | Chronic Retention (CROU) |
|---|---|---|
| Onset | Sudden | Gradual |
| Pain | Painful | Usually painless |
| Symptoms | Cannot pass urine at all | Vague lower abdominal distension |
| Example | Benign prostatic obstruction | Hypocontractile bladder |
| Bladder | Tense, tender | Large, non-tender |
| Overflow incontinence | Possible | Common |
AROU is defined as "sudden inability to pass urine" — a common reason for hospital admission in Urology. Can occur in both males and females [1].
Incidence in men [1]:
- ~7 per 1,000 men per year
- Cumulative 4-year probability: 3%
- Over 5 years: 10% of men in their 70s and ~30% of men in their 80s will experience AROU
Risk factors for male AUR (Olmsted County Study) [1]:
- Increasing age
- Increasing prostate size
- Increasing BPH symptoms
- Decreasing maximal urine flow rate
Incidence in women [1]:
- ~3 per 100,000 per year (much rarer than in men)
- Bladder outlet obstruction less common
- A proportion has detrusor underactivity (DUA)
Three mechanisms of AROU [1]:
| Mechanism | Description | Examples |
|---|---|---|
| Increased resistance to urine flow | ||
| — Mechanical | Physical blockage | Urethral stricture, clots, stone |
| — Dynamic | Functional narrowing | Enlarged prostate / bladder neck tone |
| — Functional | Neurological dysfunction | Neuropathic bladder |
| Impaired detrusor contractions | Cannot generate adequate voiding pressure | Drug-induced (antimuscarinics), bladder overdistension (post-anaesthesia), neuropathic bladder |
| Combination | Both obstruction + poor contractility | Most common in practice |
3.4 Causes of AROU
Common obstructive causes in males [1]:
- BPH (most common, ~53%)
- Cancer of prostate
- Bladder/Urethral stone
- Bladder neck stenosis (usually after previous prostate surgery)
- Urethral stricture (iatrogenic or infection/inflammation)
- Phimosis
- Bladder tumour
- Clot retention (severe gross haematuria)
Precipitating factors of AROU [1]:
- Constipation
- UTI
- Anaesthesia / analgesia
- Immobility
- Painful peri-anal conditions (e.g. thrombosed haemorrhoids, perianal abscess)
- Excessive fluid intake (esp. alcohol)
- Drugs:
- With anticholinergic S/E: antipsychotic, antispasmodics, H1 antihistamines, antidepressants, ipratropium, disopyramide
- With sympathomimetic S/E: cold medications, MDMA
Drug-Induced AROU
This is a classic exam trap. ANY drug with anticholinergic properties can precipitate AROU in a man with pre-existing BPH. Common culprits: first-generation antihistamines (chlorpheniramine), tricyclic antidepressants, opioids. Sympathomimetics (e.g. pseudoephedrine in cold medications) increase α1-mediated bladder neck tone → dynamic obstruction.
Important distinction [1]: Urinary retention ≠ anuria or oliguria Causes of no urine production:
- Pre-renal ARF: dehydration, shock
- Renal ARF: drug-induced, ATN, nephritis
In retention, the kidneys ARE making urine — it just can't get out. The bladder is full and distended. In anuria/oliguria, the bladder is empty because the kidneys aren't producing urine.
4. Bladder Outlet Obstruction (BOO)
BOO is more common in men [1]:
| Sex | Causes |
|---|---|
| Male — Anatomical | BPH, urethral stricture, stone, tumour |
| Male — Functional | Sphincter dyssynergia |
| Female | Post-operation (e.g. after surgery for stress incontinence) |
Key Conceptual Distinction (Hald Diagram)
Three commonly confused concepts [2]:
- BOO = urodynamic diagnosis (high detrusor pressure + low flow rate)
- LUTS = clinical symptoms (can be from BOO, OAB, or other causes)
- BPE (Benign Prostatic Enlargement) = clinical finding (LUTS + enlarged prostate on DRE)
NOT all LUTS is from BPH. NOT all enlarged prostates cause BOO. NOT all BOO causes LUTS. Treatment must be individualized to the component causing the problem.
Complications progress from bladder → upper tract [1]:
- Retention of urine — acute or chronic
- Recurrent UTI
- Formation of bladder calculi
- Hydroureter and hydronephrosis
- Renal impairment / ARF (Obstructive uropathy)
Why this progression occurs: Chronic obstruction → increased residual urine → stasis → UTI and stone formation. Chronically elevated intravesical pressure → transmitted backwards to ureters and kidneys → hydroureter/hydronephrosis → if bilateral and persistent → obstructive nephropathy → renal failure.
4.4 Investigating BOO
Uroflowmetry [1]:
- NOT sufficient to diagnose outlet obstruction
- Cannot distinguish obstruction from poor detrusor contractility
- Qmax 15-20 mL/sec = "normal"
- Qmax < 10 mL/sec = "abnormal"
- 47% of BOO patients have Qmax < 10 mL/s (PPV 70%)
- 82% of BOO patients have Qmax < 15 mL/s (PPV 67%)
- 18% are obstructed despite Qmax > 15 mL/s
Key point: Uroflowmetry is a SCREENING tool, not a diagnostic tool. A man with weak detrusor muscle and a man with BOO can both have low Qmax. You need pressure-flow studies to differentiate.
Urodynamic studies [1]:
- Study function of the lower urinary tract
- Parameters measured: intravesical pressure, rectal pressure, detrusor pressure (deduced), uroflow rate, sphincter function EMG, bladder volume, cystogram/reflux (video)
- BOO = "Low uroflow rate with high detrusor pressure" = Urodynamic diagnosis
| Diagnosis | Flow Rate | Detrusor Pressure |
|---|---|---|
| BOO | ↓ Low | ↑ High |
| Detrusor underactivity | ↓ Low | ↓ Low |
| Normal | Normal | Normal |
BOO is a urodynamic diagnosis [1]
5. Benign Prostatic Hyperplasia (BPH)
BPH is a histological diagnosis: benign proliferation of both glandular epithelium and stromal tissue in the transitional zone of the prostate [3]. It is androgen-dependent, driven primarily by dihydrotestosterone (DHT), which is converted from testosterone by 5α-reductase within the prostate.
BPH causes obstruction through two components [3]:
- Static component: Physical enlargement of the prostate compresses the urethra (mediated by DHT → stromal hyperplasia) → target of 5α-reductase inhibitors (finasteride, dutasteride)
- Dynamic component: Smooth muscle contraction in the prostate/bladder neck via α1 receptors → target of α1-blockers (tamsulosin, alfuzosin)
Organized by level [3]:
| Level | Complication |
|---|---|
| Prostate | Bleeding (ruptured dilated bladder neck veins) |
| Bladder | AROU, recurrent UTI, bladder stone, diverticulum, chronic ROU ± overflow incontinence |
| Upper tract | Hydronephrosis, obstructive uropathy, renal failure |
| Feature | BPH | CA Prostate |
|---|---|---|
| Size | Enlarged (>3 finger breadths) | Variable |
| Consistency | Smooth, rubbery | Hard, irregular |
| Median sulcus | Present | Obliterated |
| Nodules | Absent | Present |
| Tenderness | Non-tender | Non-tender (unless prostatitis) |
| Mobility | Mobile | May be fixed |
A validated 7-question tool quantifying LUTS severity [2]:
- 4 voiding symptoms: incomplete emptying, intermittency, weak stream, straining
- 3 storage symptoms: frequency, urgency, nocturia
- Plus 1 quality-of-life question
- Score interpretation: Mild 1-7, Moderate 8-19, Severe 20-35
- Used to guide treatment and monitor response — NOT a diagnostic tool
| Class | Examples | Mechanism | Indication | Key Side Effects |
|---|---|---|---|---|
| α1-blockers | Tamsulosin*, Alfuzosin*, Terazosin, Doxazosin | Relax smooth muscle at bladder neck/prostate (dynamic component) | Predominantly voiding symptoms; most commonly prescribed | Postural hypotension, nasal congestion, retrograde ejaculation |
| 5α-reductase inhibitors | Finasteride, Dutasteride | Inhibit testosterone → DHT conversion; shrink prostate (static component) | Large prostate; takes 6-12 months to work | Erectile dysfunction, decreased libido, gynaecomastia; halves PSA |
| Antimuscarinics | Oxybutynin, Solifenacin | Block M3 on detrusor → reduce involuntary contractions | Predominantly storage symptoms | Dry mouth, constipation, can cause retention — CI if PVR ≥ 200 mL |
| PDE5 inhibitors | Tadalafil | Smooth muscle relaxation (mechanism unclear) | LUTS + concomitant erectile dysfunction | Headache, flushing |
*Tamsulosin, alfuzosin, doxazosin are more uroselective α1A blockers [3].
- TURP (Transurethral Resection of Prostate) — gold standard surgical treatment
- Indications for surgery: failed medical therapy, recurrent AROU, recurrent UTI, bladder stones, renal impairment from BOO, recurrent haematuria
- Complications: TUR syndrome (hyponatraemia from irrigation fluid absorption), retrograde ejaculation, urethral stricture, bladder neck stenosis
6. Clinical Management of Urinary Retention
History 1 [1]:
- Confirm urinary retention — check first catheterized urine volume
- Painful vs painless retention
- First episode or recurrent
- Preceding LUTS
- Other BPH complications: gross haematuria, UTI (fever/dysuria), bladder/urethral stone (strangury), renal impairment (uraemic symptoms)
History 2 [1]:
- Precipitating factors of AROU
- Lower limb weakness/numbness + overflow incontinence/faecal incontinence → SUSPECT ACUTE SPINAL CORD COMPRESSION
- Constitutional symptoms / multiple bone pain → Suspect metastatic CA prostate
History 3 [1]:
- Medications: BPH medications (alpha blockers / 5-ARI), anticholinergics etc.
- Previous prostate surgery (e.g. TURP) or urethral instrumentation
- History of STD especially gonococcal/non-gonococcal urethritis (→ urethral stricture)
- History of CVA / Parkinsonism / Spinal surgery (→ neurogenic bladder)
Red Flags in AROU
Always ask about lower limb weakness/numbness and faecal incontinence [1]. If present → suspect acute spinal cord/cauda equina compression → EMERGENCY MRI and neurosurgical referral.
Physical Examination 1 [1]:
- Vital signs: Is the patient septic? Is the patient uraemic?
- Abdominal exam: Palpable urinary bladder (if not yet catheterized), any phimosis
- Urethral catheter output: any gross haematuria?
Physical Examination 2 [1]:
- Digital Rectal Examination (DRE):
- Anal tone and peri-anal sensation (test sacral nerve integrity)
- Prostate estimated size
- Clinical features suspicious of prostate cancer (hard, nodular, obliterated sulcus)
- Prostate tenderness (prostatitis)
- Faecal impaction (precipitating cause)
- Any painful peri-anal conditions
- Lower limb neurological deficit
Management 1 — Immediate decompression of bladder [1]:
- Urethral catheterization (first line)
- Suprapubic catheterization (SPC) (if urethral route fails or contraindicated)
SPC Indications [1]:
- Failed urethral catheterization
- History of urethral trauma (e.g. straddle injury)
SPC Contraindications [1]:
- Non-distended bladder
- Uncorrected bleeding tendency
- Known/suspected urothelial cancer
SPC Complications [1]:
- Bowel perforation
- Rectal injury (overshoot)
- Haematuria
Investigations [1]:
- CBP (complete blood picture)
- L/RFT (liver and renal function tests)
- CSU × C/ST (catheter specimen of urine for culture and sensitivity)
- KUB (plain X-ray of kidneys, ureters, bladder)
- No PSA — likely falsely elevated (in the acute setting with catheter in situ, manipulation, UTI)
Do NOT Check PSA in AROU
PSA is falsely elevated in AROU due to prostate manipulation, urethral catheterization, UTI, and acute retention itself. Wait at least 6 weeks after the acute episode before checking PSA [1].
| Category | Symptoms | Mnemonic | Typical Cause |
|---|---|---|---|
| Storage (Irritative) | Frequency, Urgency (± urge incontinence), Nocturia | FUN | OAB, UTI, stone, tumour, post-RT |
| Voiding (Obstructive) | Dribbling, Intermittency, Straining, Hesitancy, weak stream, incomplete emptying | DISH | BPH, urethral stricture, CA prostate |
| Post-micturition | Terminal dribbling, incomplete emptying, double voiding | Obstruction below sphincter |
From GC 209 [4]:
Chronic retention with overflow incontinence may be complicated with UTI, bladder stone formation. Chronic retention caused by BPH and other causes of outlet obstruction may eventually lead to obstructive uropathy and deterioration of renal function.
Overflow incontinence is the clinical manifestation of chronic retention — the bladder is so full it "overflows." The patient may report constant dribbling or bed-wetting. This is different from urge incontinence (OAB) or stress incontinence (pelvic floor weakness).
10. Exam Intelligence
| Trap | Correct Understanding |
|---|---|
| "LUTS = BPH" | LUTS is non-specific. Can be caused by OAB, UTI, bladder cancer, neuropathy. LUTS ≠ BPH |
| "Large prostate = BOO" | Prostate size poorly correlates with BOO severity. Small prostates can cause significant obstruction |
| "Low Qmax = BOO" | Uroflowmetry cannot distinguish BOO from detrusor underactivity. Need pressure-flow study |
| "Check PSA in AROU" | PSA falsely elevated in retention. Do NOT check acutely |
| "BOO = clinical diagnosis" | BOO is a URODYNAMIC diagnosis (high Pdet + low Qmax) |
| "BPH predisposes to CA prostate" | No — BPH is transitional zone, CA prostate is peripheral zone |
| "Painless retention = acute" | Painless retention is usually CHRONIC |
| Overflow incontinence confused with urge incontinence | Overflow = chronic retention + dribbling; Urge = detrusor overactivity + sudden urge |
- α1-blocker vs 5-ARI: α1-blockers work within days (quick relief); 5-ARI takes 6-12 months (for large prostates)
- Uroflowmetry vs Pressure-flow study: Uroflowmetry = screening (Qmax only); Pressure-flow = diagnostic (Qmax + Pdet)
- IPSS vs urodynamics: IPSS = symptom severity tool; Urodynamics = objective diagnosis of BOO
- Urethral cath vs SPC: SPC only if urethral cath fails or urethral trauma; never SPC into non-distended bladder
Past Paper Questions
Stem: "A 60-year-old gentleman with good past health presented to you with LUTS that are bothersome to him. Physical examination revealed no remarkable findings except an enlarged prostate to 50 ml with normal consistency and no suspicious nodules. Which of the following investigations can diagnose underlying bladder outlet obstruction in this gentleman?"
Options:
- A. Filling cystometry
- B. International prostate symptom scores (IPSS) measurement
- C. Pressure flow study ✓
- D. Uroflowmetry
Answer: C. Pressure flow study
Rationale: BOO is a urodynamic diagnosis defined by low uroflow rate + high detrusor pressure. Only pressure-flow study measures both parameters. Uroflowmetry (D) measures flow only and cannot distinguish BOO from detrusor underactivity. IPSS (B) is a symptom questionnaire, not diagnostic. Filling cystometry (A) assesses storage function, not voiding obstruction.
Q22 Stem: "A 68-year-old man was recently found with elevated PSA of 6.7 ng/mL. He received a transrectal ultrasound-guided prostate biopsy this morning. He came to the A&E at night with severe LUTS. Temperature 38.2°C, raised WBC and neutrophils. Bedside USG showed ~500 mL of urine."
Answer: A. Acute prostatitis
Rationale: Post-TRUS biopsy + fever + LUTS + raised inflammatory markers = acute prostatitis. This is a known complication of prostate biopsy. The 500 mL residual indicates retention precipitated by prostatic swelling/infection.
Q23 Stem: "A 73-year-old woman with osteoporosis was hit by a bicycle, sharp low back pain, rested in bed with NSAIDs for several days. Progressive difficulty urinating. Bladder upper border 5 cm above pubic symphysis."
Answer: E. Medications side effect (OR F. Neurologic impairment — depends on mark scheme interpretation)
Rationale: Immobility + NSAIDs + possible spinal injury → retention. The combination of bed rest, analgesics (both opioids and potentially anticholinergic co-prescriptions), and possible spinal trauma makes medication side effect the most testable answer in this EMQ context, though neurological impairment from vertebral fracture with cord/nerve compression is also plausible.
Q24 Stem: "A 75-year-old man came to A&E with retention and incontinence for half a day. Progressive difficulty urinating and increased nocturia for many years, never sought treatment. Could not urinate this morning but had continuous leakage."
Answer: B. Benign prostatic hyperplasia
Rationale: Long history of progressive LUTS (hesitancy, nocturia) in an elderly man who now presents with acute-on-chronic retention with overflow incontinence. Classic BPH presentation with decompensation.
Stem: "An 80-year-old man complains of long standing LUTS, including hesitancy, frequency and needing to strain and sense of incomplete emptying. His family finds he always wets the bed at night. What is the MOST LIKELY cause of his incontinence?"
Options:
- A. Functional incontinence
- B. Overflow incontinence ✓
- C. Stress incontinence
- D. Urge incontinence
Answer: B. Overflow incontinence
Rationale: Long-standing obstructive LUTS (hesitancy, straining, incomplete emptying) → chronic retention → the bladder is chronically full and overflows → bed-wetting = overflow incontinence. Urge incontinence (D) would present with sudden urgency then leakage, not chronic obstructive symptoms. Stress incontinence (C) occurs with cough/straining and is more common in women. Functional incontinence (A) requires physical/cognitive impairment preventing the patient from reaching the toilet.
Stem: "80-year-old gentleman admitted via A&E with gross haematuria. On-and-off painless haematuria for 3 months. Weight loss 5 kg. Presented with passage of clots and inability to void. Chronic smoker. Palpable bladder. DRE: benign 50g prostate."
Q3 (Section 2): Name two immediate urological treatments for this patient. (4 marks)
Markscheme:
- Urethral catheterization (with three-way catheter for clot evacuation)
- Continuous bladder irrigation (to prevent re-clotting)
Rationale: This is clot retention — one of the listed causes of AROU in the lecture. The inability to void is because blood clots are blocking the bladder outlet. A three-way catheter allows both drainage and continuous irrigation.
Stem: "Which of the following statements BEST describes stress urinary incontinence?"
Options:
- A. It is a more common problem in female. ✓
- B. It is associated with frequent urinary tract infection.
- C. It is more severe when patient is sleeping at night.
- D. It is typically associated with a strong sense to void followed by involuntary loss of urine.
Answer: A
Rationale: Though this is about stress incontinence rather than AROU, it's relevant to differentiating types of incontinence. Option D describes urge incontinence. Option B describes overflow incontinence (chronic retention). Option C would suggest nocturnal polyuria or overflow.
Stem: "A 70-year-old man has a history of chronic neck pain. Sustains a fall causing hyperextension of his neck. X-rays show multiple osteophytes and narrowing of spinal canal. MRI shows hyperintense signals on T2 within cervical spinal cord. What is MOST LIKELY on clinical examination?"
Options:
- A. Clumsy hand movement ✓
- B. Foot drop
- C. Loss of proprioception in lower limbs
- D. Urinary retention
Answer: A. Clumsy hand movement
Rationale: This is central cord syndrome (hyperextension injury in cervical spondylosis → central cord haemorrhage/oedema). Central cord syndrome classically affects upper limbs > lower limbs (because upper limb tracts are more centrally located). Urinary retention (D) can occur but is NOT the most likely finding — clumsy hand movement from upper limb weakness/UMN signs is more characteristic. This question tests the nuance that not all spinal cord pathology presents with urinary retention first.
High Yield Summary
-
Normal micturition requires coordinated switching between storage (sympathetic ON, parasympathetic OFF, somatic ON) and voiding (parasympathetic ON, sympathetic OFF, somatic OFF), orchestrated by the PMC with cortical permission.
-
AROU = sudden, painful inability to void; most common in elderly men due to BPH. CROU = gradual, painless; often neuropathic.
-
Key receptors: β3 (detrusor relaxation), α1 (bladder neck contraction), M3 (detrusor contraction), nicotinic (external sphincter contraction).
-
BOO is a urodynamic diagnosis — low flow + high detrusor pressure. Uroflowmetry alone is insufficient.
-
BPH obstruction has static (anatomical — 5-ARI) and dynamic (smooth muscle — α-blocker) components.
-
Precipitating factors for AROU: constipation, UTI, anaesthesia, immobility, drugs (anticholinergics, sympathomimetics), peri-anal conditions, alcohol.
-
Red flags in AROU: lower limb weakness + faecal incontinence → spinal cord compression; bone pain + constitutional symptoms → metastatic CA prostate.
-
Management: Immediate catheterization → SPC if urethral fails → Investigate (CBP, RFT, CSU, KUB) → NO PSA acutely.
-
SPC contraindications: non-distended bladder, uncorrected coagulopathy, suspected urothelial cancer.
-
Overflow incontinence = chronic retention + continuous dribbling — differentiate from urge incontinence (OAB) and stress incontinence (pelvic floor weakness).
Active Recall - Lecture Notes
[1] Lecture slides: GC 180. Benign prostatic hyperplasia, bladder outlet obstruction and urinary retention.pdf [2] Senior notes: Ryan Ho Urogenital.pdf (Section 8.3) [3] Senior notes: Maksim Surgery Notes.pdf (Section 2.4 LUTS & BPH); MBBS Final MB (Surgery) (Felix PY Lai).pdf (BPH chapter) [4] Lecture slides: GC 209. Urinary incontinence and overactive bladder.pdf (p30 - overflow incontinence) [5] Past papers: 2021 Fourth Summative Assessment MCQ.pdf (Q76) [6] Past papers: 2023 Fourth Summative MCQ.pdf (EMQ Section VI, Q22-24) [7] Past papers: 2024 Fourth Summative MCQ.pdf (Q62) [8] Past papers: 2020 Fourth Summative Minicases.pdf (Case Two, Sections 2-5) [9] Past papers: 2020 Fourth Summative Assessment MCQ paper.pdf (Q54) [10] Past papers: 2025 Fourth Summative MCQ.pdf (Q88)
GC179 Anal Pain Perianal Lesions And Sepsis
Anal pain with perianal lesions and sepsis encompasses conditions such as perianal abscesses, fistulae, fissures, and thrombosed hemorrhoids that may present with localized pain, swelling, and potential systemic infection if inadequately treated.
GC181 Breast Mass Breast Cancer; Benign Breast Diseases; Mammography; Breast Cancer Screening
A breast mass is a localized swelling in the breast that may represent benign conditions such as fibroadenoma, fibrocystic changes, or cysts, or malignant disease such as breast carcinoma, evaluated through clinical examination, mammography, and tissue sampling as part of a triple assessment approach.